How organizations are wresting with back-to-work plans in light of the Delta variant.
Plus, Why We Should Still Be Thinking About Cumulative Population Immunity
Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.
An Analysis of Infection Odds Based on US County
Our new model projects the chance that within a gathering of random people, there's an active COVID-19 infection.
Timeline to Normalcy - Updated March 15, 2021
Our revised analysis and state-by-state outlook suggest the US may achieve pHIT in early summer if vaccinations align with a more optimistic scenario.
Female CEOs on Leadership, Transformation, and the Path Forward for Parity
Our new gender parity research focuses on nine leaders who defied the odds to transform their organization and industry.
Five Healthcare Predictions
2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.
Timeline to Normalcy - Updated January 25, 2021
The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.
Featured in The Dallas Morning News
Executives who care about diversity should examine the track in their companies to senior management.
New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.